A pharmacist in the children's hospital pharmacy was opening a bd 20 ml sterile ll lf syringe.The technicians noticed that there is some sticky like residue in the 20ml bd syringes and when the plunger is pushed back, condensation appears.They checked 15 of the 20 syringes and they all appeared to be the same.Manufacturer response for 20ml syringe, (brand not provided) (per site reporter): (b)(6) made several inquiries and then manufacturer sent a letter closing the investigation by the end of march stating there was no sample for evaluation.In april, (b)(6) inquired with a representative once again and discovered (b)(6) had held up the defective sample delivery because the off-shore bd facility contact person was not available to accept the package.A month later, (b)(6) requested this be escalated within the customer service at bd.In mid-june, bd informed (b)(6) that the product is still in customs and the case will remain closed.They would open the case if the product arrives to bd.Escalated to vendor relations at (b)(6) as we have sequestered product across the entire health system.
|